RGNX Insider Trading Activity and SEC Form 4 Filings
RGNX insider trading summary
Over the past 12 months, insiders at REGENXBIO Inc. (RGNX) reported 5 sales worth $940K by 1 insider and 2 open-market purchases worth $949K by 1 insider on SEC Form 4. Net insider buying was $9K.
Latest RGNX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 27, 2026 | Gregory Austin Ciongoli | Insider | Buy | $500K (53,407 @ $9.36) |
| Aug 26, 2026 | Gregory Austin Ciongoli | Insider | Buy | $450K (49,196 @ $9.14) |
| Jul 2, 2026 | Steve Pakola | Chief Medical Officer | Sell | $29K (2,161 @ $13.64) |
| Jul 1, 2026 | Steve Pakola | Chief Medical Officer | Sell | $472K (36,725 @ $12.86) |
| Jun 29, 2026 | Steve Pakola | Chief Medical Officer | Sell | $216K (19,608 @ $11.04) |
| May 11, 2026 | Steve Pakola | Chief Medical Officer | Sell | $169K (15,309 @ $11.02) |
| Mar 10, 2026 | Steve Pakola | Chief Medical Officer | Sell | $53K (5,124 @ $10.35) |
| Oct 9, 2025 | Curran Simpson | Chief Executive Officer | Sell | $263K (20,811 @ $12.62) |
| Sep 29, 2025 | Curran Simpson | Chief Executive Officer | Sell | $76K (7,624 @ $10.03) |
| Sep 10, 2025 | Curran Simpson | Chief Executive Officer | Sell | $77K (7,734 @ $10.02) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.